Requisite models for strategic commissioning: the example of type 1 diabetes. (Q46517834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18581816%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Requisite models for strategic commissioning: the example of type 1 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18581816%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18581816%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mónica D. Oliveira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18581816%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Mara Airoldi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18581816%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Gwyn Bevan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18581816%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jenifer Smith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18581816%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18581816%20AND%20SRC:MED&resulttype=core&format=json

Health Care Management Science

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18581816%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18581816%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18581816%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

89-110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18581816%20AND%20SRC:MED&resulttype=core&format=json

Measuring the quality of medical care. A clinical method

9 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10729-008-9056-9

Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10729-008-9056-9

Evaluating screening policies for the early detection of retinopathy in patients with non-insulin dependent diabetes

21 January 2018

1 reference

12 December 2020

Diabetes prevalence in England, 2001--estimates from an epidemiological model

1 reference

12 December 2020

The cost-effectiveness of intensive therapy for diabetes mellitus

1 reference

12 December 2020

Economics of coronary artery bypass grafting

1 reference

12 December 2020

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

1 reference

12 December 2020

All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999.

1 reference

12 December 2020

Archimedes: a trial-validated model of diabetes

1 reference

12 December 2020

Geographical variation in mortality from conditions amenable to medical intervention in England and Wales

1 reference

12 December 2020

Research into the use of health economics in decision making in the United Kingdom--Phase II. Is health economics 'for good or evil'?

1 reference

12 December 2020

Calculating the global burden of disease: time for a strategic reappraisal?

1 reference

12 December 2020

Generalized cost-effectiveness analysis for national-level priority-setting in the health sector

1 reference

12 December 2020

The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus

1 reference

12 December 2020

Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Disease progression and cost of insulin dependent diabetes mellitus: development and application of a simulation model

1 reference

12 December 2020

Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.

1 reference

12 December 2020

The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Population-based survey and analysis of trends in the prevalence of diabetic nephropathy in Type 1 diabetes

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes

1 reference

12 December 2020

The prevalence and incidence of lower extremity amputation in a diabetic population

1 reference

12 December 2020

Estimation of the prevalence of diagnosed diabetes from primary care and secondary care source data: comparison of record linkage with capture-recapture analysis

1 reference

12 December 2020

Progress and directions in refining the global burden of disease approach: a response to Williams

1 reference

12 December 2020

Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more

1 reference

12 December 2020

NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care

1 reference

12 December 2020

The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy.

1 reference

12 December 2020

Implementing the findings of health technology assessments. If the CAT got out of the bag, can the TAIL wag the dog?

1 reference

12 December 2020

Burden of disease and priority setting.

1 reference

12 December 2020

Time to reassess strategies for improving health in developing countries

1 reference

12 December 2020

The health care costs of diabetic nephropathy in the United States and the United Kingdom.

1 reference

12 December 2020

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

1 reference

12 December 2020

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

12 December 2020

Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis.

1 reference

12 December 2020

Insulin adjustment by a diabetes nurse educator improves glucose control in insulin-requiring diabetic patients: a randomized trial

1 reference

12 December 2020

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).

1 reference

12 December 2020

The prevalence of multiple diabetes-related complications

1 reference

12 December 2020

Diabetes Control and Complications Trial (DCCT). Update. DCCT Research Group

1 reference

12 December 2020

Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting

1 reference

12 December 2020

The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus

1 reference

12 December 2020

The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective

1 reference

12 December 2020

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database

1 reference

12 December 2020

Prediction of resources needed to achieve the national target for treatment of renal failure

1 reference

12 December 2020

Incidence of end-stage renal disease in patients with type 1 diabetes

1 reference

12 December 2020

Economic evaluation under managed competition: evidence from the U.K.

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

The use of economic evaluation in health care: Australian decision makers' perceptions

1 reference

12 December 2020

Cost per quality-adjusted life year and disability-adjusted life years: the need for a new paradigm

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy

1 reference

12 December 2020

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

1 reference

12 December 2020

Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure.

1 reference

12 December 2020

Relation of ocular and systemic factors to survival in diabetes

1 reference

12 December 2020

Understanding DALYs (disability-adjusted life years)

1 reference

12 December 2020

Estimating the "avoidable" burden of disease by Disability Adjusted Life Years (DALYs).

1 reference

12 December 2020

The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060.

1 reference

12 December 2020

Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders

1 reference

12 December 2020

Methods to assess the costs and health effects of interventions for improving health in developing countries

1 reference

12 December 2020

Epidemiology of diabetic retinopathy and macular oedema: a systematic review

1 reference

12 December 2020

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years

1 reference

12 December 2020

Development and validation of the Economic Assessment of Glycemic Control and Long-Term Effects of diabetes (EAGLE) model.

1 reference

12 December 2020

The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years

1 reference

12 December 2020

Model of complications of NIDDM. I. Model construction and assumptions.

1 reference

12 December 2020